Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Molecular Therapeutics|October 8, 2004
Encapsulated, genetically modified cells producing in vivo therapeuticsOliver Hauser, Eva Prieschl-Grassauer, Brian Salmons
International Journal of General Medicine|March 11, 2017
Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throatMartina Morokutti-Kurz, Christine Graf, Eva Prieschl-Grassauer
Virology Journal|September 27, 2008
Iota-Carrageenan is a potent inhibitor of rhinovirus infectionAndreas Grassauer, Regina Weinmuellner, Christiane Meier, et al.
International Archives of Allergy and Immunology|December 22, 2012
Escin inhibits type I allergic dermatitis in a novel porcine modelWolfgang Sipos, Benjamin Reutterer, Maria Frank, et al.
International Journal of General Medicine|July 18, 2018
Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitisChristine Graf, Andreas Bernkop-Schnürch, Alena Egyed, et al.
BMC Immunology|May 22, 2010
Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammationInes Lindner, Christiane Meier, Angelika Url, et al.
Basic & Clinical Pharmacology & Toxicology|April 22, 2010
Pre-clinical safety evaluation of pyrrolidine dithiocarbamateMonika Chabicovsky, Eva Prieschl-Grassauer, Joachim Seipelt, et al.
Multidisciplinary Respiratory Medicine|November 21, 2014
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trialsMartin Koenighofer, Thomas Lion, Angelika Bodenteich, et al.
Pageof 3